Northern Trust’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-946,050
| Closed | -$8.49M | – | 4290 |
|
|
2016
Q3 | $8.49M | Sell |
946,050
-54,857
| -5% | -$390K | ﹤0.01% | 2186 |
|
|
2016
Q2 | $5.38M | Buy |
1,000,907
+41,619
| +4% | +$213K | ﹤0.01% | 2406 |
|
|
2016
Q1 | $4.41M | Buy |
959,288
+18,585
| +2% | +$74.7K | ﹤0.01% | 2483 |
|
|
2015
Q4 | $4.89M | Buy |
940,703
+29,503
| +3% | +$171K | ﹤0.01% | 2474 |
|
|
2015
Q3 | $5.51M | Buy |
911,200
+19,317
| +2% | +$237K | ﹤0.01% | 2381 |
|
|
2015
Q2 | $14.1M | Buy |
891,883
+174,914
| +24% | +$2.12M | ﹤0.01% | 1839 |
|
|
2015
Q1 | $7.79M | Buy |
716,969
+11,357
| +2% | +$116K | ﹤0.01% | 2216 |
|
|
2014
Q4 | $7.42M | Sell |
705,612
-21,155
| -3% | -$207K | ﹤0.01% | 2232 |
|
|
2014
Q3 | $6.97M | Buy |
726,767
+895
| +0.1% | +$9.14K | ﹤0.01% | 2283 |
|
|
2014
Q2 | $8.38M | Sell |
725,872
-86,696
| -11% | -$789K | ﹤0.01% | 2165 |
|
|
2014
Q1 | $8.13M | Sell |
812,568
-60,069
| -7% | -$867K | ﹤0.01% | 2251 |
|
|
2013
Q4 | $11.4M | Buy |
872,637
+28,667
| +3% | +$395K | ﹤0.01% | 1994 |
|
|
2013
Q3 | $12.6M | Buy |
843,970
+59,929
| +8% | +$718K | ﹤0.01% | 1846 |
|
|
2013
Q2 | $7.33M | Buy |
+784,041
| New | +$5.31M | ﹤0.01% | 2148 |
|
Northern Trust's RPTP Position: Q4 2016 in Review
Northern Trust sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 946,050 shares — an estimated $8.49M sold.
Northern Trust first reported a position in RPTP in Q2 2013 and held it in 14 quarters. The position peaked at $14.1M in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.
- Northern Trust reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
- Northern Trust sold 946,050 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $8.49M.
- Northern Trust first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 14 quarters.
- Northern Trust's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $14.1M in Q2 2015.
- 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.
Based on Northern Trust's 13F filing for Q4 2016, filed 13 Feb 2017.